Congratulations to Dr Susan Galbraith on being appointed Executive Vice President, Oncology R&D. An outstanding oncologist, Susan has a strong track record of delivering breakthrough science over the past decade at AstraZeneca, resulting in practice-changing new medicines to treat many types of cancer.
Publications
Our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement.
We have
160
projects in our pipeline
